Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Med Virol ; 95(12): e29251, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-38054522

RESUMO

Since May 2022, over 91 000 cases of mpox have been reported globally with the majority of cases occurring among adult males who identify as gay, bisexual, or men who have sex with men (gbMSM). Given the rapid emergence of the global mpox outbreak, many public health authorities did not have established mpox outbreak control indicators or criteria for declaring an mpox outbreak over. Expert consensus in Ontario, Canada, set thresholds for five key indicators of mpox outbreak control as follows: estimated number of currently infectious cases < 5; effective reproductive number < 1.0; doubling time > 42 days; weekly test positivity < 5%; and sporadic non-gbMSM cases (i.e., female and pediatric cases). Once all indicators were achieved, a 52-day period based on two incubation periods for mpox and a 10-day reporting delay was employed to monitor for indicator stability. After all five indicators remained at expected levels, the mpox outbreak in Ontario was declared over on December 10, 2022. Despite current low levels of mpox activity globally, some jurisdictions may benefit from utilizing or modifying these outbreak control indicators during a future localized mpox outbreak.


Assuntos
Mpox , Minorias Sexuais e de Gênero , Adulto , Masculino , Feminino , Humanos , Criança , Ontário/epidemiologia , Homossexualidade Masculina , Surtos de Doenças
2.
BMC Public Health ; 23(1): 1443, 2023 07 28.
Artigo em Inglês | MEDLINE | ID: mdl-37507665

RESUMO

BACKGROUND: This report describes two L. monocytogenes outbreak investigations that occurred in March and September of 2018 and that linked illness to a food premises located in an Ontario cancer centre. The cancer centre serves patients from across the province. METHODS: In Ontario, local public health agencies follow up with all reported laboratory-confirmed cases of listeriosis to identify possible sources of disease acquisition and to carry out investigations, including at suspected food premises. The Canadian Food Inspection Agency (CFIA) is notified of any Listeria-positive food product collected in relation to a case. The CFIA traces Listeria-positive product through the food distribution system to identify the contamination source and ensure the implicated manufacturing facility implements corrective measures. RESULTS: Outbreaks one and two each involved three outbreak-confirmed listeriosis cases. All six cases were considered genetically related by whole genome sequencing (WGS). In both outbreaks, outbreak-confirmed cases reported consuming meals at a food premises located in a cancer centre (food premises A) before illness onset. Various open deli meat samples and, in outbreak two, environmental swabs (primarily from the meat slicer) collected from food premises A were genetically related to the outbreak-confirmed cases. Food premises A closed as a result of the investigations. CONCLUSIONS: When procuring on-site food premises, healthcare facilities and institutions serving individuals with immuno-compromising conditions should consider the potential health risk of foods available to their patient population.


Assuntos
Doenças Transmitidas por Alimentos , Listeria monocytogenes , Listeriose , Neoplasias , Humanos , Listeria monocytogenes/genética , Doenças Transmitidas por Alimentos/epidemiologia , Microbiologia de Alimentos , Neoplasias/epidemiologia , Listeriose/epidemiologia , Surtos de Doenças , Ontário/epidemiologia
4.
New Dir Stud Leadersh ; 2021(172): 29-34, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-35061318

RESUMO

Events, movements, and tragedies at the local, national, and global levels spark conversations that influence leaders' thinking and behavior. Understanding complexities of contextual factors as they relate to broader conversations and influence thinking and behaviors is a crucial step that can be overlooked. This article explores utilizing critical perspectives and social justice to inform leadership praxis.


Assuntos
Liderança , Justiça Social , Humanos
5.
New Dir Stud Leadersh ; 2021(172): 35-43, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-35061319

RESUMO

Leadership educators often acknowledge the need to embrace and honor diverse lived experiences and different ways we acquire knowledge and demonstrate leadership. However, do our practices and expectations really reflect this? How do we ensure we are not perpetuating expectations and structures rooted in White supremacist culture?


Assuntos
Liderança , Comportamento Social , Humanos
6.
New Dir Stud Leadersh ; 2021(172): 19-27, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-35061321

RESUMO

The confluence of crises facing our global and local communities have challenged leadership educators to think and practice differently. This has meant shifts in how we teach, how we connect with students, and how we understand our role in making change in our institutions and communities. How can we navigate change personally and as a community? The purpose of this article is to introduce co-inquiry as an emerging method for professional community building, leadership learning, and action-oriented research.


Assuntos
Liderança , Aprendizagem , Humanos
7.
New Dir Stud Leadersh ; 2021(172): 45-52, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-35061322

RESUMO

This article is an exploration into the purpose of leadership education and leadership learning in higher education. It will simultaneously explore who leadership education is for and investigate privilege, identities, class, and the intersecting impact on access to these programs and content.


Assuntos
Liderança , Aprendizagem , Humanos
8.
Vaccine ; 28(3): 858-63, 2010 Jan 08.
Artigo em Inglês | MEDLINE | ID: mdl-19716458

RESUMO

The Government of Bangladesh and WHO collaborated in a retrospective vaccine wastage study to estimate overall vaccine wastage rates from January to December 2004 for BCG, measles, DTP and TT. Researchers looked at vaccine distribution and usage patterns in randomly selected districts at both fixed (Upazila) and outreach (Ward) service delivery levels. Wastage was similar at both delivery levels but ranged widely among the sites. Average rates were highest for BCG (84.9%, range 55-93%) and measles (69.7%, range 28-86%) and lower for TT (35.5%, range 10-73%) and DTP (44.4%, range 16-77%). Wastage resulted primarily from opened vials at the ward level but this was reduced at fixed sites where the multi-dose vial policy is followed. A large proportion (30-38%) of records were excluded from the analytic vaccine-specific databases due to data recording errors, mismatches between Ward and Upazila databases, or missing data. The study's results may provide methodological and programmatic guidance for other countries in addressing vaccine wastage issues.


Assuntos
Revisão de Uso de Medicamentos , Uso de Medicamentos/estatística & dados numéricos , Vacinas/uso terapêutico , Bangladesh , Humanos , Lactente , Recém-Nascido , Estudos Retrospectivos , Organização Mundial da Saúde
9.
Emerg Infect Dis ; 14(1): 25-33, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18258073

RESUMO

The International Circumpolar Surveillance System is a population-based surveillance network for invasive bacterial disease in the Arctic. The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced for routine infant vaccination in Alaska (2001), northern Canada (2002-2006), and Norway (2006). Data for invasive pneumococcal disease (IPD) were analyzed to identify clinical findings, disease rates, serotype distribution, and antimicrobial drug susceptibility; 11,244 IPD cases were reported. Pneumonia and bacteremia were common clinical findings. Rates of IPD among indigenous persons in Alaska and northern Canada were 43 and 38 cases per 100,000 population, respectively. Rates in children <2 years of age ranged from 21 to 153 cases per 100,000 population. In Alaska and northern Canada, IPD rates in children <2 years of age caused by PCV7 serotypes decreased by >80% after routine vaccination. IPD rates are high among indigenous persons and children in Arctic countries. After vaccine introduction, IPD caused by non-PCV7 serotypes increased in Alaska.


Assuntos
Cooperação Internacional , Infecções Pneumocócicas/epidemiologia , Streptococcus pneumoniae , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Regiões Árticas/epidemiologia , Criança , Pré-Escolar , Clima Frio , Controle de Doenças Transmissíveis/métodos , Farmacorresistência Bacteriana Múltipla , Feminino , Humanos , Programas de Imunização , Lactente , Masculino , Pessoa de Meia-Idade , Vacinas Pneumocócicas/uso terapêutico , Grupos Populacionais , Vigilância da População , Sorotipagem , Streptococcus pneumoniae/classificação , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/imunologia
10.
Emerg Infect Dis ; 14(1): 34-40, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18258074

RESUMO

International Circumpolar Surveillance (ICS) is a population-based invasive bacterial disease surveillance network. Participating Canadian regions include Yukon, Northwest Territories, Nunavut, and northern regions of Québec and Labrador (total population 132,956, 59% aboriginal). Clinical and demographic information were collected by using standardized surveillance forms. Bacterial isolates were forwarded to reference laboratories for confirmation and serotyping. After pneumococcal conjugate vaccine introduction, crude annual incidence rates of invasive Streptococcus pneumoniae decreased from 34.0/100,000 population (1999-2002) to 23.6/100,000 population (2003-2005); substantial reductions were shown among aboriginals. However, incidence rates of S. pneumoniae, Haemophilus influenzae, and group A streptococci were higher in aboriginal populations than in non-aboriginal populations. H. influenzae type b was rare; 52% of all H. influenzae cases were caused by type a. Data collected by ICS contribute to the understanding of the epidemiology of invasive bacterial diseases among northern populations, which assists in formulation of prevention and control strategies, including immunization recommendations.


Assuntos
Infecções Meningocócicas/mortalidade , Infecções Estreptocócicas/mortalidade , Adolescente , Adulto , Distribuição por Idade , Fatores Etários , Idoso , Regiões Árticas/epidemiologia , Canadá/epidemiologia , Criança , Pré-Escolar , Humanos , Incidência , Lactente , Recém-Nascido , Infecções Meningocócicas/complicações , Pessoa de Meia-Idade , Vigilância da População , Infecções Estreptocócicas/complicações
11.
Emerg Infect Dis ; 14(1): 48-55, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18258076

RESUMO

Before the introduction of Haemophilus influenzae type b (Hib) conjugate vaccines, rates of invasive H. influenzae disease among indigenous people of the North American Arctic were among the highest in the world. Routine vaccination reduced rates to low levels; however, serotype replacement with non-type b strains may result in a reemergence of invasive disease in children. We reviewed population-based data on invasive H. influenzae in Alaska and northern Canada from 2000-2005; 138 cases were reported. Among 88 typeable isolates, 42 (48%) were H. influenzae type a (Hia); 35 (83%) occurred in indigenous peoples. Among Hia patients, median age was 1.1 years; 62% were male; 1 adult died. Common clinical manifestations included meningitis, pneumonia, and septic arthritis. Overall annual incidence was 0.9 cases per 100,000 population. Incidence among indigenous children <2 years of age in Alaska and northern Canada was 21 and 102, respectively. Serotype a is now the most common H. influenzae serotype in the North American Arctic; the highest rates are among indigenous children.


Assuntos
Infecções por Haemophilus/epidemiologia , Haemophilus influenzae/classificação , Adolescente , Adulto , Fatores Etários , Idoso , Alaska/epidemiologia , Regiões Árticas/epidemiologia , Canadá/epidemiologia , Criança , Pré-Escolar , Feminino , Haemophilus influenzae/patogenicidade , Humanos , Incidência , Lactente , Inuíte/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Vigilância da População , Sorotipagem
12.
Can J Infect Dis ; 13(3): 195-207, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-18159391

RESUMO

OBJECTIVE: To discuss the occurrence of genital chlamydia in developed countries and review the literature assessing the potential risk factors for this sexually transmitted disease. DATA SOURCES: A MEDLINE search was performed for all English citations from 1985 to 2000 that contain the keywords "Chlamydia trachomatis", "chlamydial infections", "risk factors" and "sex behaviour". All relevant references cited in articles that were obtained from the search were also included. DATA EXTRACTION: ALL ARTICLES OBTAINED FROM THE ABOVE SOURCES WERE EXAMINED, AND WERE INCLUDED IN THE REVIEW IF THEY MET THE FOLLOWING CRITERIA: primary study examining sociodemographic or behavioural risk factors associated with genital chlamydial infection using multivariate analysis; study subjects 12 years of age and older; and study setting in a developed country. DATA SYNTHESIS AND CONCLUSIONS: Genital chlamydial infection has become the most commonly reported bacterial infection in North America over the past decade. Thirty-eight cross-sectional studies and six cohort studies were included in the present review. Most studies demonstrated that young men and women are at higher risk of being infected with chlamydia than older subjects. Chlamydia seems to be found in a diverse group of people, and unlike gonorrhea, is not concentrated in low income, minority core groups with high rates of partner change. However, a number of studies have shown that communities with well-established control programs are beginning to demonstrate this pattern. There is no clear evidence that chlamydia is associated with type of partners, contraceptive use, or age at first intercourse. Future research should follow this sexually transmitted disease as it evolves through the epidemiological stages to ensure that preventive and treatment services are reaching those people who are most likely to be infected.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA